Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Sourcinglink.Net Inc (SNET)

Sourcinglink.Net Inc (SNET)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,286
  • Shares Outstanding, K 124,896
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta 3.10
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0063 +63.49%
on 06/10/19
0.0210 -50.95%
on 05/13/19
-0.0107 (-50.95%)
since 05/10/19
3-Month
0.0063 +63.49%
on 06/10/19
0.0360 -71.39%
on 04/09/19
-0.0036 (-25.90%)
since 03/12/19
52-Week
0.0060 +71.67%
on 02/26/19
0.0360 -71.39%
on 04/09/19
+0.0003 (+3.00%)
since 06/05/18

Most Recent Stories

More News
Healthcare Companies Search for New Ways to Oppose the Spread of Cancer

Cancer is among one of the leading causes of death in the world since many countries are burdened by the lack of access to adequate healthcare, which results in the high number of deaths. In 2018, the...

SNETD : 0.3900 (+14.71%)
SNET : 0.0103 (+63.49%)
CVM : 7.89 (+1.15%)
CRIS : 1.41 (+1.44%)
GERN : 1.38 (+5.34%)
NLNK : 1.62 (+1.25%)
Biotechs Strive to Provide Patients With More Affordable Treatment Options

The American Cancer Society estimated that in 1991, cancer deaths peaked at 215 deaths per 100,000 persons. As of 2014, the rate dropped significantly to just 161 deaths per 100,000 persons, representing...

SNETD : 0.3900 (+14.71%)
SNET : 0.0103 (+63.49%)
ATOS : 1.22 (-2.40%)
AGEN : 4.37 (+0.23%)
SNSS : 0.41 (unch)
OMED : 0.93 (+4.49%)
Health Tech Aim to Change the Way Cancer is Treated

In 2018, there was an estimated 1.73 million new cancer cases diagnosed and 609,640 cancer deaths in the U.S., according to the American Cancer Society. The organization expects cancer cases to continue...

SNETD : 0.3900 (+14.71%)
SNET : 0.0103 (+63.49%)
CLDX : 2.28 (+7.04%)
AVEO : 0.65 (+3.17%)
DARE : 0.83 (+1.22%)
SRRA : 0.25 (unch)
Biotech Firms Strive to Combat the Growing Burden of Diseases With Innovative Technologies

NEW YORK, April 4, 2019 The global burden of diseases continues to grow each year, despite various ongoing medical advancements. In 2017, the Institute for Health Metrics and Evaluation (IHME) said in...

SNETD : 0.3900 (+14.71%)
SNET : 0.0103 (+63.49%)
ARQL : 8.73 (+3.19%)
SRNE : 1.57 (+3.29%)
SNSS : 0.41 (unch)
ONCS : 2.07 (+0.49%)
Veterinary Oncology Licensing Agreement Signed Between SourcingLink.net and NanoSmart Pharmaceuticals, Inc.

via NEWMEDIAWIRE -- SourcingLink.net, Inc. (SNET), a San Francisco, CA based company, announced today that it entered into an exclusive, worldwide licensing agreement with NanoSmart Pharmaceuticals, Inc...

SNET : 0.0103 (+63.49%)
SNETD : 0.3900 (+14.71%)
Therapies Trying to Fight Against Cancer

Over the past two decades, U.S. cancer-related deaths have significantly declined. As of 2015, the death rate for both men and women declined by 26% from its peak in 1991, according to the American Cancer...

SNETD : 0.3900 (+14.71%)
SNET : 0.0103 (+63.49%)
INO : 2.48 (+4.64%)
AGEN : 4.37 (+0.23%)
GILD : 65.04 (+0.06%)
CVM : 7.89 (+1.15%)
APTO : 2.50 (+0.40%)
APS.TO : 3.35 (+0.90%)
Therapies Trying to Fight Against Cancer

Over the past two decades, U.S. cancer-related deaths have significantly declined. As of 2015, the death rate for both men and women declined by 26% from its peak in 1991, according to the American Cancer...

SNETD : 0.3900 (+14.71%)
SNET : 0.0103 (+63.49%)
INO : 2.48 (+4.64%)
AGEN : 4.37 (+0.23%)
GILD : 65.04 (+0.06%)
CVM : 7.89 (+1.15%)
APTO : 2.50 (+0.40%)
APS.TO : 3.35 (+0.90%)
SourcingLink.net Enters into an Exclusive Worldwide Licensing Agreement with NanoSmart Pharmaceuticals for Anti-Nuclear Antibody (ANA)-Targeted Doxorubicin Formulations to Treat Cancer

via NEWMEDIAWIRE - SourcingLink.net, Inc. (SNET), announced today that it entered into an exclusive worldwide licensing agreement with NanoSmart Pharmaceuticals, Inc. for the right to use NanoSmart's nanoparticle...

SNET : 0.0103 (+63.49%)
SNETD : 0.3900 (+14.71%)
Biotech Companies Turn Their Attention to Cancer as Global Incidences Grow

In 2018, cancer was the second leading cause of death around the globe. Cancer was responsible for an estimated 9.6 million deaths in that year, or approximately one in six deaths, according to the World...

SNETD : 0.3900 (+14.71%)
SNET : 0.0103 (+63.49%)
CANF : 2.47 (+2.49%)
CYCC : 0.46 (+2.22%)
BLRX : 2.64 (-0.75%)
ONCS : 2.07 (+0.49%)
Biotech Companies Intensify Research Into New Therapies to Combat Cancer

Cancer ranks among one of the top causes of death globally and data show that the number is still expected to increase. The National Cancer Institute stated in 2012 there were 14.1 million new cases of...

SNETD : 0.3900 (+14.71%)
SNET : 0.0103 (+63.49%)
AST : 0.94 (unch)
GNCA : 2.25 (+0.90%)
CYTR : 0.2755 (+2.04%)
NWBO : 0.2113 (-1.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade SNET with:

Key Turning Points

2nd Resistance Point 0.0129
1st Resistance Point 0.0116
Last Price 0.0103
1st Support Level 0.0084
2nd Support Level 0.0065

See More

52-Week High 0.0360
Fibonacci 61.8% 0.0245
Fibonacci 50% 0.0210
Fibonacci 38.2% 0.0175
Last Price 0.0103
52-Week Low 0.0060

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar